New injection makes fat cells self-destruct
ScienceDaily, using materials from the European Association for the Study of Diabetes, reports on CBL-514, an experimental injection designed to make fat cells self-destruct. In a small phase 2 MRI analysis (n=23 drug, n=17 placebo), visceral fat fell an average 12.01% four weeks after the final injection while placebo recipients' rose 5.68%. Reduced weight regain after stopping tirzepatide was seen only in rats; phase 3 recruitment is underway.
Why it matters: Relevant to Maryland adults exploring medical weight loss or nonsurgical fat-reduction options, and to clinicians who field patient questions about experimental abdominal-fat treatments.
A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to sciencedaily.com. October 12, 2026.
